The latest data point for CVX's Return on Sales (ROS) in Q4'25 stands at 10.42%, reflecting a modest quarterly uptick from Q3'25's 11.48% but continuing a broader softening in profitability metrics amid ongoing market pressures. Over the period from Q2'23 to Q4'25, ROS exhibited an overall declining trend, starting at a robust 16.28% and peaking at 16.40% in Q1'24 before steadily eroding to the current 10.42%, with notable volatility including a sharp drop to 7.69% in Q4'23 and a temporary recovery in Q1'24. This downward trajectory highlights potential challenges in cost management or revenue efficiency, as the area chart reveals consistent erosion post-peak without significant inflection points for reversal.